These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 10570513)

  • 1. [24 hour blood pressure and impairement of renal function].
    Poch E; Redón J
    Med Clin (Barc); 1999 Oct; 113(12):452-5. PubMed ID: 10570513
    [No Abstract]   [Full Text] [Related]  

  • 2. [Subclinical albuminuria, microalbuminuria and proteinuria--accepted cardiovascular risk markers?].
    Schmieder RE; Schrader J; Zidek W; Tebbe U; Bramlage P; Paar WD; Böhm M
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2665-71. PubMed ID: 17109277
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic kidney disease as a situation of high added risk in hypertensive patients.
    Segura J; García-Donaire JA; Praga M; Ruilope LM
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S136-40. PubMed ID: 16565238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations].
    Hornych A; Marre M; Mimran A; Chaignon M; Asmar R; Fauvel JP;
    Arch Mal Coeur Vaiss; 2000 Nov; 93(11):1304-8. PubMed ID: 11190459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mild renal insufficiency and microalbuminuria as emerging cardiovascular risk factors].
    Gorostidi M
    Nefrologia; 2004; 24 Suppl(6):47-61, 187-235. PubMed ID: 15696896
    [No Abstract]   [Full Text] [Related]  

  • 6. [Arterial hypertension and the kidney].
    Niang A
    Dakar Med; 2008; 53(1):1-6. PubMed ID: 19102111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diurnal variation of blood pressure in type II diabetic patients].
    Przewłocka-Kosmala M; Bańcarz A; Kosmala W
    Pol Merkur Lekarski; 1999 Dec; 7(42):253-5. PubMed ID: 10710947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive renal vascular disease and cardiovascular endpoints.
    Matavelli LC; Zhou X; Frohlich ED
    Curr Opin Cardiol; 2006 Jul; 21(4):305-9. PubMed ID: 16755198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension-induced renal failure.
    Zucchelli PC; Pavlica P; Zuccalà A; Losinno F; Barozzi L
    J Nephrol; 2001; 14(1):52-67. PubMed ID: 11281346
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency.
    Giri S; Mahajan SK; Sen R; Sharma A
    J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-albuminuria as a predictor of cardiovascular damage in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Mangano MT; Carapelle E; Nardi E; Andronico G; Fulantelli MA; Marcellino T
    J Hypertens Suppl; 1989 Dec; 7(6):S332-3. PubMed ID: 2632735
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing vascular events due to elevated blood pressure.
    Yusuf S
    Circulation; 2006 May; 113(18):2166-8. PubMed ID: 16684871
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of guidelines for the management of hypertension in cardiovascular risk scoring of renal patients.
    Mazzaferro S; Barresi G; Baldinelli M; Malagnino E; Matera G; Otranto G; Pasquali M; Pugliese F
    Clin Ter; 2006; 157(4):327-32. PubMed ID: 17051969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents.
    Phillips JK
    Clin Exp Pharmacol Physiol; 2005; 32(5-6):415-8. PubMed ID: 15854151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microalbuminuria: do we need a new threshold?
    Zamora CR; Cubeddu LX
    J Hum Hypertens; 2009 Feb; 23(2):146-9. PubMed ID: 18784737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
    Dell'Omo G; Penno G; Pucci L; Fotino C; Lucchesi D; Del Prato S; Pedrinelli R
    J Hypertens; 2007 Jul; 25(7):1389-95. PubMed ID: 17563560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
    Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
    Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of ambulatory blood pressure monitoring in kidney disease].
    Robles NR; Cancho B; Crespo E; Sanchez Casado E
    Nefrologia; 2001; 21(1):65-70. PubMed ID: 11344964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.